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Several corneal pathologies are characterized by the presence of reactive oxygen species (ROS); therefore, we evaluated the
protection afforded by pirenoxine and melatonin to corneal cell culture and whole rabbit cornea from ultraviolet exposure and other
oxidant systems.
Rabbit cornea cell (SIRC) plates and whole corneas were exposed to UV-B (80 or 800 mJ/cm2) or incubated with fMLP-
stimulated autologous macrophages, in the presence or absence of pirenoxine or melatonin (105 M). The protective activity of
compounds was assessed by measuring superoxide anion formation, inhibition of oxidation and mitochondrial viability. Moreover
the ex vivo protective effect of pirenoxine and melatonin was verified in the whole cornea submitted to UV-B exposure in vitro.
Our experimental data demonstrate that pirenoxine andmelatoninwere able to inhibit the superoxide formation and oxidative effect
in cell culture andwhole rabbit corneas submitted toUV-B exposure or to incubation with fMLP-stimulated autologousmacrophages.
Mitochondrial viability was restored in epithelial cells of rabbit cornea but not in SIRCs.
Moreover, both compounds are also able to increase ex vivo epithelial corneal cell defences against the in vitro UV-B induced lipid
peroxidation.
 2003 Elsevier B.V. All rights reserved.
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Pathological conditions of corneal tissue, character-
ized by the presence of reactive oxygen species (ROS)with
a consistent increase in oxidative insult and a decrease in
antioxidant system components, are produced by physi-
ological and non-physiological environmental stress,
such as ultraviolet (UV) radiation, aging, bacterial and
viral infections, hypoxia-reoxygenation and trauma. In-
deed, the effect of UV light has been extensively investi-
gated [1–8]. It has been reported that biotoxic
epiphenomenamay take place when the threshold level of
radiation absorbed in corneal tissues is exceeded, and,
consequently, permanent keratocyte damage or loss, ep-* Corresponding author. Tel.: +39-055-4271220/222; fax: +39-055-
4271280.
E-mail address: mario.ciuffi@unifi.it (M. Ciuffi).
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occur, as well as biochemical changes, such as ROS pro-
duction, protein cross-linking, enzyme inactivation,
DNAstrandbreaks and chemotactic factor release [9–13].
The presence and epiphenomena of ROS, polymorpho-
nuclear cell recruitment, keratocyte loss and development
of a diffuse anterior stromal cornea haze are also observed
when excimer laser therapy is applied in treating myopia,
astigmatism and corneal opacities [14–17].
Moreover, the extension of stromal healing response
characterized by an augmentation of subepithelial haze
in corneas submitted to excimer laser treatment followed
by UV-B exposure could be ascribable to ROS activity
prevailing over the epithelial antioxidant system [18,19].
Thus, physiological scavenging agents, such as super-
oxide dismutase (SOD), catalase, vitamin E, glutathi-
one, ascorbic acid, as well as steroidal or non-steroidal
anti-inflammatory molecules, have been tested in order
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the side effects of excimer laser therapy on the cornea
[20–25].
In this context, the aim of our research was to eval-
uate in vitro the protection afforded by some radical
scavengers to an eye derived cell line in culture and
tissues of rabbit cornea when free radical attacks
were triggered using UV-B radiation or other oxidant
systems.
Therefore, we utilized SIRC cultures and whole rab-
bit corneas. Although in experimental models, SIRCs
are described and used as being of epithelial origin
[26–28], their morphology, ultrastructure and antigenic
properties indicate a fibroblast origin for this cell line
[29].
Since in our former work we have already demon-
strated that pirenoxine (1-hydroxy-5H-pyrido-(3,2-a)-
phenoxazin-5-one-3-carboxylic acid sodium salt), likely
via a free radical scavenging mechanism, is able to
prevent or inhibit lipid peroxidative degeneration of
lenses which can eventually lead to cataract formation
[30], in the present study we analyse the protective effect
of this molecule in corneal cell culture and whole cornea
in both in vitro and ex vivo experiments.
Pirenoxine is a xanthomatin (an ommochrome found
in the ocular pigment of several insects) derived com-
pound, already known for its therapeutic effectiveness in
suppressing the progress of senile cataract in human
eyes (Catalin: Takeda et al.) [31–33].
Moreover, we evaluate the effect of the pineal neuro-
hormone melatonin (N-acetyl-5-methoxy-tryptamine).
Melatonin is synthesized also in retinal photoreceptor
cells and in the ciliary body of the eye and appears to
exert protective actions against light-stimulated pro-
duction of ROS [34–36]. In some tests, we compare the
protective effect of pirenoxine and melatonin to that of
a-tocopherol (physiological scavenger of hydroxyl radi-
cal) and thioctic acid (a scavenger molecule also able to
neutralize superoxide anion) [37,38]. Our experimental
data suggest that pirenoxine and melatonin are able to
decrease lipid peroxidation and protect the mitochon-
drial viability of corneal epithelial cells or the whole
rabbit corneas when the ROS attack is triggered by UV
light or other ROS-producing systems in vitro.Moreover
both compounds are able to increase epithelial corneal
cell defences in ex vivo.2. Materials and methods
2.1. Materials
Melatonin, () a-tocopherol, DL-6,8-thioctic acid
(reduced form), SOD (EC 1.15.1.1), minimum essential
medium (MEM), Hanks balanced salt solution (HBSS)without phenol red, reduced glutathione (GSH) and
antibiotic-antimycotic solution were purchased from
Sigma Chemical Co. (MO, USA). All reagents were of
the highest commercially available analytical grade.
Pirenoxine sodium salt was kindly donated by Farmigea
(Pisa, Italy).
2.2. Isolated cultured eye cells
SIRCs were initially plated at a density of 4 104
cells/cm2 in 25 cm2 flasks with MEM–HBSS (2 mM L-
glutamine, 1% non-essential amino acid solution, 10%
foetal bovine serum, 100 U/ml penicillin G, 100 lg/ml
streptomycin, 0.25 lg/ml amphotericin B; pH 7) and
allowed to proliferate until 100% confluence in 5% CO2
incubator at 37 C (medium was changed every 2 days).
After treatment with 0.25% trypsin and 0.02% EDTA,
the detached cells were harvested by centrifugation at
230g for 5 min and split 1:3 in order to provide a suf-
ficient cell stock that can be frozen for repeated studies.
Forty-eight hours before the experiment, the SIRCs
were passed into 12-well plates at a density of 1.5 104
cells/well plate and used for experiment when a 70–80%
of confluence was achieved.
2.3. Tissue preparation
The investigation conforms to the European Com-
munity rules for the care and use of laboratory animals.
Male pigmented rabbits (Pampaloni, Pisa, Italy)
weighing approximately 1.3–1.7 kg upon arrival were
kept in comfortable cages under a constant light–dark
cycle (light on between 8.00 A.M. and 20.00 P.M.) and
left undisturbed for three days in order to acclimate.
Unlimited food and water were supplied. All animals
were used only once in the experiments.
For the in vitro procedure we used 10 lM pirenoxine
that we found to be the most effective concentration for
the inhibition of lipid peroxidation of lens homogenate
[33]. Melatonin was used in vitro at the same molecular
concentration.
For the ex vivo procedure, rabbit right eyes were
topically treated every hour for 8 h for 2 days with 10
nmol for administration of both compounds (i.e., 2
drops of 0.005% pirenoxine¼ 1.5 lg or 0.0038% mela-
tonin¼ 1.13 lg in 0.145 M NaCl; 1 drop 30 ll),
whereas the left eyes received only drops of the diluent.
The topical treatment ended 1 h before the sacrifice. The
0.005% concentration of the topically administered
pirenoxine was that of the commercial ophthalmic so-
lution bearing the trade-name Catalin [30–32].
All rabbits were killed with an overdose of sodium
pentobarbital (100 mg/kg e.v.) and the eyes removed.
Full thickness corneas were excised at the limbus
with a pair of scissors and processed according to the
test.
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SIRCs showing 80% confluence were incubated at
37 C for 1 h in 5% CO2 incubator in MEM–HBSS
containing 0.1% foetal bovine serum (FBS) in the pres-
ence or absence of the pirenoxine, melatonin, a-to-
copherol and thioctic acid (each at the concentration of
10 lM). Then, the medium was replaced with HBSS
containing 0.1% FBS and cells were submitted for 36 s at
room temperature to UV exposure (Vilber Lourmat
Lamp, Cedex, France: wavelength range set at 280–350
nm and peak at 312 nm), receiving in these conditions a
total equivalent energy of 80 mJ/cm2 under constant
intensity. This energy dosage was chosen since in-be-
tween to the energy quoted in vivo to induce keratitis
(140 mJ/cm2) and subkeratitis (30 mJ/cm2) [6]. After 3 h,
the medium was further substituted and SIRCs were
incubated for 18 h in a medium containing 10% FBS in
the absence (control) or presence of aforesaid sub-
stances. Plated SIRCs, without UV-B irradiation (basal
value), were likewise treated. To evaluate lipid peroxi-
dation, cells were rinsed with HBSS, scraped, harvested
by centrifugation, homogenized in HBSS and lipid sol-
uble fluorescent compounds were measured. SOD-inhi-
bitable superoxide anion formation and mitochondrial
viability were determined as described.
2.5. Irradiation with UV-B rays of corneal tissue
Whole corneas were previously incubated for 1 h at
37 C in 100 lMphosphate buffer (pH 7.4) in the absence
(control) or presence of 10 lM melatonin, pirenoxine,
thioctic acid and a-tocopherol, and then exposed (epi-
thelial side) for 36 or 360 s to UV-B light (80 or 800 mJ/
cm2) under constant intensity, wetting the surface every
60 s with 1–2 drops of physiological solution when ex-
posure was continued for 360 s. Since in several tests we
were unable to detect significant biochemical modifica-
tions in control conditions submitting corneas to 80 mJ/
cm2 UV-B radiation, we mainly performed experiments
using a 800 mJ/cm2 UV-B light.
When ex vivo procedure was performed, corneas from
eyes submitted in vivo to topical instillationswere directly
exposed to UV-B light without further treatment.
All specimens were cut into small pieces and incu-
bated for 18 h at 37 C in 100 lM phosphate buffer (pH
7.4) in the presence of 1000 U/ml collagenase type IA
(EC3.4.24.3) and 5 lM CaCl2. The obtained cell sus-
pension was centrifuged (800g at 0 C for 10 min) and
the pellet was resuspended in phosphate buffer and
washed twice by centrifugation. Cells were then ho-
mogenized in phosphate buffer by Ultraturrax (3 10 s
at 0 C). Lipid soluble fluorescent compounds, conju-
gated diene formation and GSH and oxidized glutathi-
one (GSSG) levels were evaluated. Corneas without
UV-light exposure were likewise treated (basal value).The SOD-inhibitable superoxide anion formation in
pre-treated and 800 mJ/cm2 exposed cornea was directly
assayed after incubation in 0.1% FBS medium for 3 h.
Corneal epithelial cell mitochondrial viability was
evaluated in 80 and 800 mJ/cm2 UV-B exposed and pre-
treated corneas after incubation in 0.1% FBS medium
for 3 h. The corneal tissue was then treated with dispase
(EC3.4.24.4: 2 U/ml) for 1 h at 4 C and the obtained
epithelial cell sheets digested in 0.25% trypsin at 37 C
for 5 min. After centrifugation at 230g for 5 min, the cell
pellet was suspended in 10% FBS medium and incu-
bated for 18 h, in the presence or absence of scavenger
compounds and, finally, processed for MTT assay.
In order to investigate if the protective effect of
pirenoxine and melatonin (10 lM) was exerted during a
delayed phase of damage, cells were incubated for 18 h
with drugs added only after UV-B-exposure.
2.6. Fenton reaction on SIRC and corneal tissue homo-
genate
Several plates of SIRC were washed, scraped and
harvested with HBSS in order to obtain a suspension
(approximately 2.5 106 cells/ml) and homogenized.
Corneal tissue was weighed and homogenized in HBSS
(10% w/v) by Ultraturrax (3 10 s at 0 C). Homoge-
nate aliquots (500 ll) were incubated with 10 lM FeCl3
and 100 lM ascorbic acid in the absence (control) or
presence of pirenoxine, melatonin, a-tocopherol or thi-
octic acid (each molecule at a concentrations of 10 lM)
at 37 C for 30 min in a shaking bath. Lipid soluble
fluorescent compounds formation was measured. Basal
values were calculated running parallel experiments
without the ROS generating system.
2.7. fMLP-stimulated macrophages activity on corneal
tissue
Rabbit corneas were incubated (37 C, 5% CO2 in-
cubator for 2 h) with autologous alveolar macrophages
(106 cell/dish; obtained according to Mugnai et al.) [39].
Experiments were performed using resting macrophages
(control conditions) or in 10 nM fMLP-stimulated
macrophages, with or without (control) 10 lM melato-
nin and pirenoxine. Afterwards, the specimens were re-
moved from the reaction mixture and rinsed in isotonic
saline solution containing 23 lM BHT. After the enzy-
matic treatment for epithelial component separation, the
cellular pellet was homogenized and processed for lipid
soluble fluorescent compounds determination.
2.8. Superoxide anion assay
SIRC and corneal tissue, previously rinsed with
HBSS, were incubated at 37 C for 1 h with 1 ml
cytochrome C (1 mg/ml) solution in the presence and
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550 nm was spectrophotometrically measured and the
superoxide amount calculated by using an extinction co-
efficient of 2.1 104 M1 cm1 and expressed as nmol/h.
2.9. Fluorescence assay
All samples were extracted with chloroform:methanol
mixture (2:1 v/v) according to the method of Fletcher
et al. [40]. Chloroform extract fluorescence was read by
a Perkin–Elmer 650-10 S apparatus (ex. 370 nm, em.
430 nm) and expressed as arbitrary fluorescence units/
mg proteins.
2.10. Conjugated diene assay
Homogenates were extracted [30] with chloroform/
methanol mixture (2:1 v/v) and centrifuged (1900g for 10
min). An aliquot of the chloroform phase was evapo-
rated under an argon stream and the total lipid extract
dissolved in cyclohexane. The measurement was per-
formed by scanning the absorbance spectrum between
220 and 350 nm (against cyclohexane blank) and esti-
mating the amount of conjugated dienes at 232 nm after
the elimination of the background due to Rayleigh
scattering. Data were expressed as differences between
the sample and basal absorbance values using a molar
absorption coefficient of 2.52 104 M1 cm1.
2.11. Glutathione assay
The determination of GSH and GSSG was conducted
essentially according to Hissin and Hilf [41]. The cell
pellet was homogenized in buffered solution (3 ml of 0.1
M sodium phosphate, 0.005 M EDTA buffer, pH 8, plus
1 ml of 25% (w/v) HPO3). For the GSH assay, after
centrifugation at 4 C at 100,000g for 30 min, 0.5 ml of
the supernatant was diluted with phosphate-EDTA
buffer (pH 8) to a 5 ml final volume. For the GSSG
evaluation, 200 ll of 0.04 M N-ethylmaleimide were
added to 0.5 ml of the supernatant, incubated for 30 min
and diluted with 0.1 N NaOH to a volume of 5 ml.
Phosphate-EDTA buffer and 0.1 N NaOH (1.8 ml,
respectively) and ortho-phthalaldehyde (OTP: 100 ll)
solution (1 mg/ml) were added to 100 ll of both mix-
tures. The mixtures were mixed and incubated at room
temperature for 15 min. The fluorescence developed
from the GSH–OTP or GSSG–OTP reaction was de-
termined (420 nm emission and 350 nm excitation).
Samples were calibrated using a standard curve of GSH
at different concentrations (0–10 lg/ml).
2.12. Mitochondrial viability
The MTT assay [42] was used in order to evaluate the
mitochondrial viability of UV-treated corneal cells.Corneal cell medium derived either from culture and
tissue was replaced with 800 ll DMEM without phenol
red and replenished with 400 lg thiazolyl blue. After
incubation (3 h at 37 C in 5% CO2 incubator), the cells
were rinsed with HBSS and dissolved in 1 ml of 0.01 N
HCl in isopropyl alcohol. The dark purple formazan
generated was diluted 1:5 with isopropyl alcohol and
the optical density of the samples was then measured at
570 nm.
2.13. Protein assay
Protein concentration was determined by the method
of Sedmak and Grossberg [43] using Coomassie brilliant
blue G-250 to detect microgram amounts of protein.
2.14. Statistical analysis
Data were reported as mean values SD. One-way
analysis of variance (ANOVA) followed by Bonferronis
t test was performed in order to estimate significant
differences among groups. Indeed as indicated, com-
parisons were performed among the basal, control and
treatment groups. Statistical tests were performed using
PRIMER, version 3.02 software (McGraw-Hill Com-
panies Inc.).3. Results
3.1. Effects of UV-B on SIRC
UV-B exposure (80 mJ/cm2) significantly increased
superoxide anion formation in SIRC cells to 326% of
basal value (Table 1). Pirenoxine and melatonin pre-
vented superoxide production with a similar effective-
ness and superoxide production in treated samples was
not different from basal value. Moreover, both com-
pounds inhibited the UV-B-induced increase in lipid
soluble fluorescent compounds (Table 1). Indeed, fluo-
rescence obtained in treated and exposed cells was not
significantly different from basal values (unexposed
cells). a-Tocopherol and thioctic acid (10 lM each),
used in both experimental protocols as reference com-
pounds, significantly reduced the production of super-
oxide to 4.2 1.8 and 1.7 0.4 nmol/105 cells/h,
respectively, and lipid soluble fluorescent compounds to
5.1 0.8 and 7.3 2 U/mg protein, respectively.
However, mitochondrial viability after UV-B expo-
sure was not increased by pirenoxine and melatonin.
Indeed, the mitochondrial viability, as evaluated by
MTT test, was 63.3 10%, 61.3 8.2% and 71 10% of
the basal value in control conditions, in the presence of
pirenoxine or melatonin, respectively. When drug con-
centrations were increased up to 100 lM, no different
result occurred.
Table 1
In vitro formation of SOD inhibitable superoxide and lipid soluble fluorescent compounds in SIRC cells submitted to 80 mJ/cm2 UV-B exposure with
and without pirenoxine or melatonin (10 lM)
Superoxide (nmol/105 cells/h) Fluorescence (arbitrary units/mg protein)
Without exposure (basal value) 1.9 0.7 5.8 0.8
With exposure (control) 6.2 1.4 14.3 1.5
+pirenoxine 3.3 1.0 5.7 1.6
+melatonin 3.3 0.8 5.3 2.0
Mean valuesSD were obtained from at least four tests performed in duplicate. SOD presence decreased UV-B-induced superoxide to the basal
values (1.8 1 nmol/105 cell/h). One-way ANOVA F ¼ 12:79, P < 0:001 and F ¼ 32:12, P < 0:001 superoxide and fluorescence tests, respectively.
* P < 0:05 different from all other groups, whereas other groups were not significantly different each other (Bonferronis analysis).
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UV-B exposure (800 mJ/cm2) also significantly in-
creased superoxide anion in tissue culture of rabbit
corneas (up to 138% of basal value; Table 2). Pirenoxine
and melatonin (each at the concentration of 10 lM)
totally prevented UV-B-induced superoxide anion pro-
duction. Moreover, we observed a significant increase
(179% of basal value) in lipid soluble fluorescent sub-
stances in light-exposed corneas, whereas, when the
aforesaid scavenging compounds were present in the
incubation mixture, no valuable change was observed
with respect to unexposed tissues (Table 2). a-Tocoph-
erol and thioctic acid (10 lM each) were also able to
significantly decrease the light-induced fluorescent
compounds showing the value of 2.1 1.2 and 2.8 0.7
arbitrary fluorescence units/mg protein, respectively.
Also the significant increase in conjugated dienes was
inhibited by 52.7% and 73.3%, respectively, in the
presence of pirenoxine or melatonin in the incubation
mixture. Both compounds significantly prevented GSH
oxidation, showing a GSH/GSSG ratio slightly higher
than that obtained in basal condition (Table 3).
Pirenoxine and melatonin were also able to improve
mitochondrial viability of epithelial cells obtained from
80 and 800 mJ/cm2 UV-B-exposed corneas (Fig. 1),
being pirenoxine (10 lM) slightly more effective than
melatonin after exposure to 800 mJ/cm2 UV-B. In-
creasing melatonin concentration up to 50 lM (4 cor-Table 2
Pirenoxine and melatonin affect SOD-inhibitable superoxide anion, conjugat
rabbit cornea submitted to 800 mJ/cm2 UV-B exposure
Superoxide anion
(nmol/hemicornea/h)
Corneal tissue (basal value) 92.3 16 (4)
UV exposed corneal tissue (control) 127.4 22 (10)
+pirenoxine 80.4 14 (4)
+melatonin 91.5 12 (4)
Each number SD represents the mean value (in brackets the number of
to the basal values (93.2 17.6 nmol/hemicornea/h) : expressed by the differ
P < 0:001, F ¼ 9:38, P < 0:001 and F ¼ 10:57, P < 0:001 superoxide, conjug
* P < 0:05 different from all other groups, whereas other groups were n
ANOVA for conjugated dienes was performed among control, pirenoxine aneas), the mitochondrial activity rescue resulted in
93 14% of basal value (P < 0:05 vs. control). When
epithelial corneal cells were incubated with scavenger
compounds only after 800 mJ/cm2 UV-B light exposure,
pirenoxine was still effective in preserving mitochondrial
viability (F ¼ 4:23, P < 0:05 ANOVA, pirenoxine vs.
other groups P < 0:05, Bonferronis t test) while mela-
tonin treated group was not different from control. In-
deed, mitochondrial viability was 40.4 17% (10
corneas) in control condition and 80.8 12% (P < 0:05
vs control) and 61.8 22% (5 corneas) in the presence of
pirenoxine and melatonin, respectively.
3.3. Effects of the Fenton reaction on SIRC and cornea
The lipid soluble fluorescent compound formation,
induced in SIRC cells and rabbit corneal tissue homo-
genates by Fe(III)/ascorbate oxidant system, was sig-
nificantly inhibited by scavenger compounds (Table 4).
In the presence of pirenoxine and melatonin, the fluo-
rescence value of SIRC homogenates attained the basal
value. Thioctic acid behaved similarly (11.6 1 arbitrary
fluorescence units/mg protein), while a-tocopherol
(14.2 1.6 arbitrary fluorescence units/mg protein) was
less effective. Fluorescence of corneal tissue homogen-
ates was twice as much that of SIRC (Table 4). Simi-
larly, pirenoxine and melatonin significantly dammed
the increase in lipid soluble fluorescent substances in
corneas as well as a-tocopherol (31.1 5.2 arbitraryed diene increase and lipid soluble fluorescent compound formation in
Conjugated dienes
(nmol/mg protein)
Fluorescence
(arbitrary units/mg protein)
16.6 5.2 (8) 2.4 0.3 (8)
13.1 6.4 (14) 4.3 1.1 (8)
6.2 2.3 (6) 2.2 0.4 (4)
3.5 1.2 (6) 2.5 1 (4)
processed corneas). SOD presence decreased UV-B-induced superoxide
ence between the sample and basal values. One-way ANOVA F ¼ 8:59,
ated dienes and fluorescent compounds tests, respectively.
ot significantly different each other (Bonferronis analysis). One-way
nd melatonin groups.
Table 3
Pirenoxine and melatonin affect reduced/oxidized glutathione rate in rabbit cornea submitted to 800 mJ/cm2 UV-B exposure
Reduced Oxidized Reduced/Oxidized
Glutathione (lg/mg protein) Glutathione rate
Corneal tissue (basal value; n. 6) 1.5 0.2 0.5 0.1 3.0
UV exposed corneal tissue (control; n. 8) 1.0 0.2 0.6 0.1 1.7
+pirenoxine (4) 1.5 0.3 0.4 0.1 3.7
+melatonin (4) 1.6 0.4 0.5 0.1 3.2
Each numberSD represents the mean value (the number of processed corneas is in brackets). One-way ANOVA F ¼ 7:08, P < 0:002 reduced
glutathione test.
* P < 0:05 different from all other groups, whereas other groups were not significantly different each other (Bonferronis analysis).
Fig. 1. Effect of pirenoxine (pir.) or melatonin (mel.) on epithelial cell
mitochondrial viability of rabbit cornea after exposure to 80 or 800
mJ/cm2 UV-B. Data are means SD (the number of processed corneas
is in brackets). Corneas (20) without UV-B exposure (basal value:
100%) showed 0.442 0.083 absorbance/mg protein at 570 nm. One-
way ANOVA (performed among control, pirenoxine and melatonin
groups) F ¼ 58:71, P < 0:001 and F ¼ 15:53, P < 0:001 for 80 and 800
mJ/cm2 exposed cornea respectively. *P < 0:05 different from all other
groups, whereas other groups were not significantly different from each
other (Bonferronis analysis).
Table 4
Effect of 10 lM pirenoxine or melatonin on the extent of peroxidation
induced by ascorbate/Fe3þ in the homogenates of SIRC and tissues of
rabbit corneas
Fluorescence (arbitrary
units/mg protein)
SIRC Corneal tissue
Homogenate (basal value) 10.8 1.0 26.6 2.9
Iron-stimulated homogenate (control) 18.2 1.8 41.9 4.0
+pirenoxine 11.5 1.4 32.1 3.6
+melatonin 11.8 1.0 34.0 3.4
Each valueSD represents the mean of at least four determina-
tions (performed in duplicate). One-way ANOVA F ¼ 26:33,
P < 0:001 and F ¼ 13:11, P < 0:001 SIRC and corneal tissue fluores-
cence, respectively.
* P < 0:05 different from all other groups, whereas other groups were
not significantly different each other (Bonferronis analysis).
64 M. Ciuffi et al. / Journal of Photochemistry and Photobiology B: Biology 71 (2003) 59–68fluorescence units/mg protein) and thioctic acid (29.3 6
arbitrary fluorescence units/mg protein).
3.4. Effects of autologous macrophages action on the
cornea
Incubation of rabbit corneas with fMLP-stimulated
autologous macrophages produced a 142% increase in
lipid soluble fluorescent compound formation with re-
spect to the cornea value obtained after incubation with
unstimulated macrophages. This increase was inhibited
by adding 10 lM pirenoxine or melatonin to the incu-
bation mixture (Fig. 2).
3.5. Ex vivo effects of pirenoxine on the cornea
Pirenoxine and melatonin (topically administered in
vivo to rabbit eyes) induced a significant decrease
(75.2% and 55.3%, respectively) in conjugated dieneFig. 2. Effect of 10 lM pirenoxine and melatonin on lipid soluble
fluorescent compound formation in the epithelium of rabbit corneas
after incubation with fMLP-stimulated autologous macrophages.
Data SD represent the mean values (the number of processed cor-
neas is in brackets). One-way ANOVA F ¼ 6:16, P < 0:01. *P < 0:05
different from all other groups, whereas other groups were not sig-
nificantly different each other (Bonferronis analysis).
Fig. 3. Ex vivo effects of pirenoxine or melatonin instillations in rabbit
eyes on the conjugated dienes increase in corneas submitted to 800 mJ/
cm2 UV-B light in vitro. Each valueSD represents the mean value,
expressed by difference between the sample and basal value (corneas
from eyes with saline instillation, but without UV-B exposure:
23.9 5.4 nmol/mg protein). The number of processed specimens is in
brackets. One-way ANOVA (performed among control, pirenoxine
and melatonin groups) F ¼ 20:49, P < 0:01. *P < 0:05 different from
all other groups, whereas other groups were not significantly different
each other (Bonferronis analysis).
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ison with those of saline-instilled eyes (Fig. 3).4. Discussion
Our data demonstrate that scavenger compounds as
pirenoxine and melatonin protect SIRC and the whole
rabbit cornea from ROS activity in vitro induced by
different systems, such as UV-B radiation, Fe(III)/
ascorbate and macrophage oxidative burst.
In our experimental model, UV-B radiation signifi-
cantly increased superoxide formation in exposed SIRC
and rabbit corneas, probably indicating a functional
damage to the electron transport chain of mitochondria
[44] and elevated xanthine oxidase activity [45,46]. All
tested molecules successfully inhibited superoxide anion
formation. However, since pirenoxine [30], melatonin
[47] and a-tocopherol are reported to be hydroxyl rad-
ical scavengers, it seems likely that neutralization of
these hyperactive substances, produced after UV-B ex-
posure, can protect the mitochondrial apparatus and
prevent an increase in xanthine oxidase activity. On the
other hand, thioctic acid, a compound also having su-
peroxide-scavenger activity [38] and, in this case,
working with a potency similar to SOD, totally pre-
vented O2 formation, suggesting that the UV-B injury
of SIRC and corneas can be due to an excessive super-
oxide production (O2 !H2O2!HO).
A similar mechanism of hydroxyl radical neutraliza-
tion can also explain the prevention of the lipid-soluble
fluorescent compound formation by pirenoxine, mela-tonin, a-tocopherol and thioctic acid in SIRC and whole
rabbit corneas. Lipid soluble fluorescent substances
(produced by the reactions of degraded lipids with the
amino groups of proteins) are believed to be epiphe-
nomena of ROS activity and a sign of stable oxidation
end-products [48].
Other ROS-dependent alterations (i.e., conjugated
diene increase and contemporaneous depletion of
physiological cellular glutathione) found in rabbit cor-
neal tissue submitted to 800 mJ/cm2 UV-B exposure are
also ascribable to an initial superoxide production fol-
lowed by hydrogen peroxide and hydroxyl radical for-
mation. Since the conjugated diene increase is an early
sign of polyunsaturated lipid structure alteration [49]
and glutathione depletion is an indicator of cellular
oxidative stress [50], our experimental data demonstrate
that pirenoxine and melatonin protect membrane lipid
components and cellular antioxidant defences by exert-
ing their ROS scavenging activities.
The protective effect of pirenoxine, melatonin and
other scavengers as a-tocopherol and thioctic acid in
both SIRC and whole corneas, are also confirmed in
vitro using an aggressive metal-catalysed oxidant sys-
tem. The fluorescence calculated as arbitrary units per
milligram of protein is higher in the corneal tissue than
in SIRC. Indeed it is likely that the release of other
fluorescent substances produced by the ROS-generating
system on articulate arrangement of corneas can justify
this increase [8,51,52].
By producing extracellular matrix, fibroblasts are
known to pilot cell differentiation, migration and ad-
hesion, with pro-healing and anti-inflammatory effects
[18,53,54], therefore the protection against UV-B or
Fenton reaction-induced ROS, exerted by both com-
pounds on SIRC, may acquire a considerable impor-
tance. Indeed SIRC, being basically fibroblasts
(keratocytes), possess a low (or absent) expression of
some epithelial enzymes suitable to inhibit the ROS at-
tack [48,55,56].
Our data show that the mitochondrial viability is
reduced in SIRC culture and cornea by UV-B exposure,
but the presence of pirenoxine and melatonin totally
prevent the mitochondrial viability decrease in cells of
corneas after exposition to 80 or 800 mJ/cm2 UV-B.
Moreover, it is interesting to note that pirenoxine exerts
a full protection when it is present in the incubation
milieu before and after UV-B exposure, and redoubles
mitochondrial viability in comparison to control, when
added after irradiation. On the other hand, melatonin
protects mitochondrial viability only if the compound is
present during the pre-treatment and incubation. In
studies on the retina some researchers hypothesize that
melatonin can attain efficacious concentrations in the
retina micro-environment able to protect biomolecules
from free radical damage and counteract apoptosis,
since it is synthesized in situ and can therefore attain
66 M. Ciuffi et al. / Journal of Photochemistry and Photobiology B: Biology 71 (2003) 59–68high local concentration. Moreover it is reported that, as
compared to in vivo concentration, higher melatonin
dosages are necessary in vitro in order to fully scavenge
free radicals and to rescue antioxidant defences
[35,57,58]. We hypothesize that the lack of efficacy of
melatonin may be ascribable to an inadequate concen-
tration of melatonin attainable into the corneal cells.
On the other hand, both compounds are ineffective
in preserving mitochondrial viability in SIRC after
UV-B exposure, although they are able to reduce ROS
formation and lipid peroxidation. This different be-
haviour between SIRC and corneal epithelial cells may
be dependent on cell features. Indeed when exposed to
UV-B corneal fibroblastic cells demonstrate an inad-
equate protection in comparison with epithelial cells
and it is also reported that whole corneas tolerate
higher doses of UV-B radiation than cultured kera-
tocytes [1,13,59,60]. This is further consistent with the
different mitochondrial viability obtained when SIRC
cell monolayer structure and whole corneas are ex-
posed to UV-B rays, since, in the first case, the high
energy of radiation can hit directly all plated cells,
whereas only the superficial epithelial cell layer is ex-
posed in corneas (the anterior layers of human cor-
neas are particularly important in preventing damage
by UV-B radiation) [61].
With a similar aforesaid mechanism, pirenoxine and
melatonin can prevent the formation of lipid soluble
fluorescent compounds in rabbit cornea epithelium
submitted to the oxidative burst of fMLP-stimulated
autologous macrophages. Since corneal damage during
inflammation is characterized by monocytes/macro-
phages and neutrophils invasion that can release ROS,
proteolytic enzymes and arachidonic acid [25,60,62].
The indirect anti-inflammatory effect of pirenoxine
and melatonin, dependent on their scavenger activities,
can counteract several deleterious effects of inflam-
mation.
Moreover, ex vivo experiments show that pirenoxine
and melatonin repeatedly instilled in rabbit eye can in-
crease or support the antioxidant defence of the whole
cornea. Therefore, it is reasonable to assume that both
compounds topically administered in vivo in the eyes
can reach a concentration high enough to protect them
from oxidative attacks and, consequently, may be con-
sidered available tools in the treatment of eye patholo-
gies characterized by the presence of ROS. Studies are
being currently carried out in our laboratory in order to
better clarify the in vivo mechanism by which pirenoxine
and melatonin protect the cornea.Acknowledgements
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